UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004402
Receipt number R000005262
Scientific Title Evaluation of Distraction osteogenesis for severe hypoplastic maxilla or mandible
Date of disclosure of the study information 2010/11/01
Last modified on 2017/04/23 10:23:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of Distraction osteogenesis for severe hypoplastic maxilla or mandible

Acronym

Evaluation of Distraction osteogenesis for severe hypoplastic maxilla or mandible

Scientific Title

Evaluation of Distraction osteogenesis for severe hypoplastic maxilla or mandible

Scientific Title:Acronym

Evaluation of Distraction osteogenesis for severe hypoplastic maxilla or mandible

Region

Japan


Condition

Condition

Hypoplastic maxilla, hypoplastic mandible

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Maxillary distraction using halo-type devices has been a breakthrough in LeFort I maxillary advancement for cleft cases, because of the possibilities for three-dimensional correction of the hypoplastic maxilla and the stability of the advanced maxillary segment. In addition, together with the RED Retention Plate System, it allows control of the palatal plane easily during the distraction. We have reported these advantages of halo type distraction technique, but we have begun to notice the possibility that LeFort I advancement deteriorates the patient's velopharyngeal function in some cases. Furthermore, the skeletal correction with LeFort I advancement for the hypoplastic maxilla is achieved simply by forcing the small maxillary dental arch to be set for the normal size dental arch of the mandible. Therefore, some of the molars are not involved in occlusion in some cases. To improve these problems, we adopted anterior maxillary distraction osteogenesis (AMDO), similar to interdental distraction osteogenesis, for the cleft cases that exhibited severe hypoplastic maxilla and marginal velopharyngeal insufficiency. Even though AMDO has some problems yet, we expect it could be an alternative to LeFort I advancement for cleft cases. And we have also treated hemifacial microsomia cases using distraction osteogenesis technique. However it has been controversial whether mandibular distraction was effective or mandibular and maxillary distraction was necessary. To make clear the effects of distraction osteogenesis for maxillary or mandibular deformities, we are examining the records of the cases retrospectively.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

evaluation at a month, 6months, 12months after the operation
complication
occlusion
collapse of distracted segments
velopharyngeal function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Patients treated using distraction osteogenesis technique at Tohoku University Hospital in Sendai, Japan from 2000 to 2009 were included.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

over 1 year follow up

Key exclusion criteria

drop out until 1 year postoperative

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshimichi imai

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Plastic and Reconstructive Surgery

Zip code


Address

Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi-pref., JAPAN

TEL

022-717-7332

Email

yo-imai@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshimichi Imai

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Plastic and Reconstructive Surgery

Zip code


Address

Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi-pref., JAPAN

TEL

022-717-7332

Homepage URL


Email

yo-imai@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

2009-518

Org. issuing International ID_1

Ethics Committee, Tohoku University School of Medicine

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2010 Year 03 Month 29 Day

Date of IRB


Anticipated trial start date

2010 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 18 Day

Last modified on

2017 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005262